.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: RE39155

« Back to Dashboard

Summary for Patent: RE39155

Title:Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
Abstract:Use of a compound of formula (I) or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed. ##STR00001##
Inventor(s): Belleau; Pierrette (Montreal, CA), Nguyen-Ba; Nghe (La Praire, CA), Belleau; Bernard (Westmont, CA)
Assignee: Shire BioChem Inc. (Quebec, CA)
Application Number:09/585,431
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: RE39155

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9100039Jan 03, 1991
United Kingdom9109913May 07, 1991
PCT Information
PCT FiledJanuary 03, 1992PCT Application Number:PCT/CA92/00001
PCT Publication Date:July 23, 1992PCT Publication Number: WO92/11852

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc